Genexin Supplies Cervical Cancer Diagnostic Kit to Indonesia 'KDNA'

Genexin has signed a contract with Indonesia's KDNA, which is a subsidiary of Kalbe Biopharma, an Indonesian pharmaceutical company, to supply cervical cancer and sexually transmitted disease diagnostic kits.

Gynpad will be supplied through this contract. Gynpad is a pad type product that allows simple cervical cell self-harvesting by simply wearing the product without any special manipulation but for a certain period of time.

Gynpad has been developed and produced by TCM Korea and Genexin has acquired supply rights to all of Southeast Asia incluiding Indonesia, the Philippines and Singapore. 

» Read more:

EastBridge Leaps Forward to Pan-Asia Investment Company

EastBridge Partners will take a forward step to become a Pan-Asia investment company with the recent election of CEO, Dongsuk Choi from Goldman Sachs. New CEO, Dongsuk Choi, is expected to lead the acquisition of management including cross-border M&A, which is the future investment strategy of EastBridge Partners, and expansion of overseas investment, thanks to his experience and ability at Goldman Sachs IB.

» Read more:

Why Goldman Sachs CEO, Dongsuk Choi, Went to EastBridge

EastBridge Partners has electected Dongsuk Choi from Goldman Sachs IB as a new CEO. Chairman of EastBridge, Kevin Jung Gang Lim, will reside in Singapore and will focus on execution of investment throughout Asia and investor relations.

Dongsuk Choi, who has received many "Love Calls" from global PEF management and domestic conglomerates, has turned out to be a mid-sized PEF management. An industry official explained, "Mr. Choi has accepted Mr. Lim's suggestion to create a top domestic PEF management company that invests professionally throughout Asia."

EastBridge plans to acquire management of mid-sized enterprises in Asia with growth potential, such as Indonesia and Vietnam, or to acquire domestic companies, and to open overseas markets to boost up corporate value.

» Read more: